The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world data to enable large-scale assessment of WHO CNS5 glioma classification.
 
Joshuah Kapilivsky
Employment - Tempus
Stock and Other Ownership Interests - Tempus
Patents, Royalties, Other Intellectual Property - SYSTEMS AND METHODS FOR MULTI-LABEL CANCER CLASSIFICATION (Patent Application, Number 17/150,992)
 
Kimmo J. Hatanpaa
No Relationships to Disclose
 
Kabir Manghnani
Employment - Tempus
 
Timothy J. Taxter
Employment - Tempus
Stock and Other Ownership Interests - Tempus
 
Martin Stumpe
Employment - Google Health; Tempus
Leadership - Tempus
Stock and Other Ownership Interests - Google Health; Tempus
Patents, Royalties, Other Intellectual Property - About 10 patents pending from Google Health work. No royalties.; Several patents from Tempus Labs in Healthcare Technology
Travel, Accommodations, Expenses - Google Health; Tempus
 
Justin Guinney
Employment - Tempus
Consulting or Advisory Role - AstraZeneca
Research Funding - AstraZeneca (Inst); Bristol Meyers Squib (Inst); Roche/Genentech (Inst)
 
Kyle A. Beauchamp
Employment - Counsyl; Myriad Genetics; Tempus
Stock and Other Ownership Interests - Counsyl; Tempus
Patents, Royalties, Other Intellectual Property - As part of my employment at Myriad, I was listed as inventor on several submitted patents in DNA sequencing and related technologies.
 
Robin Arthur Buerki
Honoraria - IQvia
 
Alessandra Breschi
Employment - Tempus
Stock and Other Ownership Interests - Tempus
Patents, Royalties, Other Intellectual Property - Patent pending on algorithm to analyze Continuous Glucose Monitoring data; Patent pending on pipeline to discover biomarkers (Inst)